Dongming Su

2.0k total citations
34 papers, 1.6k citations indexed

About

Dongming Su is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Dongming Su has authored 34 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 15 papers in Cancer Research and 5 papers in Cell Biology. Recurrent topics in Dongming Su's work include Cancer-related molecular mechanisms research (7 papers), S100 Proteins and Annexins (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Dongming Su is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), S100 Proteins and Annexins (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Dongming Su collaborates with scholars based in China, United States and India. Dongming Su's co-authors include Mei Liang, Jian Fu, Ping Zhang, Xiubin Liang, Hangyu Li, Xiangdong Hua, Liang Yang, Xiaodong Zhang, Shibo Wei and Qing Fan and has published in prestigious journals such as PLoS ONE, Diabetes and The FASEB Journal.

In The Last Decade

Dongming Su

34 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongming Su China 22 969 555 299 299 162 34 1.6k
Lan Wang China 25 905 0.9× 338 0.6× 274 0.9× 367 1.2× 231 1.4× 74 1.8k
Daniela Verzella Italy 19 835 0.9× 497 0.9× 350 1.2× 530 1.8× 239 1.5× 34 1.7k
Qing Cao China 21 892 0.9× 491 0.9× 188 0.6× 266 0.9× 163 1.0× 79 1.5k
Yingjie Guan China 21 1.1k 1.1× 354 0.6× 543 1.8× 312 1.0× 101 0.6× 46 1.8k
Wen-Jia Chen China 23 996 1.0× 523 0.9× 345 1.2× 165 0.6× 99 0.6× 101 1.6k
Ruchika Gangwar India 26 867 0.9× 372 0.7× 263 0.9× 147 0.5× 194 1.2× 36 1.4k

Countries citing papers authored by Dongming Su

Since Specialization
Citations

This map shows the geographic impact of Dongming Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongming Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongming Su more than expected).

Fields of papers citing papers by Dongming Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongming Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongming Su. The network helps show where Dongming Su may publish in the future.

Co-authorship network of co-authors of Dongming Su

This figure shows the co-authorship network connecting the top 25 collaborators of Dongming Su. A scholar is included among the top collaborators of Dongming Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongming Su. Dongming Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Xin, Chen Wang, Wei Cai, et al.. (2024). Isthmin-1 promotes growth and progression of colorectal cancer through the interaction with EGFR and YBX-1. Cancer Letters. 590. 216868–216868. 3 indexed citations
2.
Han, Shuying, Lei Huo, Lihua Zhao, et al.. (2024). HIF-1α participates in the regulation of S100A16-HRD1-GSK3β/CK1α pathway in renal hypoxia injury. Cell Death and Disease. 15(5). 316–316. 4 indexed citations
3.
Wang, Zheng, et al.. (2022). S100A16 promotes acute kidney injury by activating HRD1-induced ubiquitination and degradation of GSK3β and CK1α. Cellular and Molecular Life Sciences. 79(3). 184–184. 21 indexed citations
4.
Li, Min, Hongwei Cai, Wenwen Zhang, et al.. (2021). Calcium Binding Protein S100A16 Expedites Proliferation, Invasion and Epithelial-Mesenchymal Transition Process in Gastric Cancer. Frontiers in Cell and Developmental Biology. 9. 736929–736929. 16 indexed citations
5.
Wang, Jia, Yuemei Xu, Yipin Wang, et al.. (2021). Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression. Cell Communication and Signaling. 19(1). 18–18. 26 indexed citations
6.
Wang, Jia, Jin Wen, Yifei Sun, et al.. (2021). CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer. Molecular Cancer. 20(1). 25–25. 89 indexed citations
7.
Xu, Fei, Yiwei Cheng, Xiao Cai, et al.. (2021). Proteomic profiling of the endogenous peptides of MRSA and MSSA. PeerJ. 9. e12508–e12508. 6 indexed citations
8.
Yang, Weijie, Jing Zhang, Boqun Xu, et al.. (2020). HucMSC-Derived Exosomes Mitigate the Age-Related Retardation of Fertility in Female Mice. Molecular Therapy. 28(4). 1200–1213. 111 indexed citations
9.
Kan, Jingbao, Jie Yang, Pei Tong, et al.. (2019). [S100 calcium binding protein A16 promotes fat synthesis through endoplasmic reticulum stress in HepG2 cells].. PubMed. 71(2). 279–286. 1 indexed citations
10.
Liu, Zhaoxia, Hai Wang, Hongwei Cai, et al.. (2018). Long non-coding RNA MIAT promotes growth and metastasis of colorectal cancer cells through regulation of miR-132/Derlin-1 pathway. Cancer Cell International. 18(1). 59–59. 59 indexed citations
11.
Huang, Yujie, Yifei Sun, Yizhi Cao, et al.. (2017). HRD1 prevents apoptosis in renal tubular epithelial cells by mediating eIF2α ubiquitylation and degradation. Cell Death and Disease. 8(12). 3202–3202. 41 indexed citations
12.
Fan, Qing, Liang Yang, Xiaodong Zhang, et al.. (2017). The emerging role of exosome-derived non-coding RNAs in cancer biology. Cancer Letters. 414. 107–115. 174 indexed citations
13.
Wei, Shibo, Qing Fan, Liang Yang, et al.. (2017). Promotion of glycolysis by HOTAIR through GLUT1 upregulation via mTOR signaling. Oncology Reports. 38(3). 1902–1908. 78 indexed citations
14.
Yi, Zhe, Yan Li, Dan Liu, et al.. (2016). Extracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathway. Tumor Biology. 37(10). 13951–13959. 25 indexed citations
15.
Li, Aimei, Zhi‐Jun Jia, Hangyu Li, et al.. (2015). Ganoderma lucidum polysaccharide extract inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation and function by inducing microRNA-125b. Journal of Translational Medicine. 13(1). 100–100. 92 indexed citations
16.
Zhao, Shigang, Yiqun Jiang, Meiping Shen, et al.. (2015). A novel mutation links to von Hippel-Lindau syndrome in a Chinese family with hemangioblastoma. Genetics and Molecular Research. 14(2). 4513–4520. 1 indexed citations
17.
Li, Hangyu, Yan Li, Dan Liu, et al.. (2013). Extracellular HSP70/HSP70-PCs Promote Epithelial-Mesenchymal Transition of Hepatocarcinoma Cells. PLoS ONE. 8(12). e84759–e84759. 32 indexed citations
18.
Su, Dongming, Gina M. Coudriet, Dae Hyun Kim, et al.. (2009). FoxO1 Links Insulin Resistance to Proinflammatory Cytokine IL-1β Production in Macrophages. Diabetes. 58(11). 2624–2633. 153 indexed citations
19.
Zhang, Ping, Dongming Su, Mei Liang, & Jian Fu. (2007). Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosis. Molecular Immunology. 45(5). 1470–1476. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026